Guard Therapeutics International AB (publ)

OM:GUARD BTA Stock Report

Market Cap: SEK 323.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Guard Therapeutics International Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GUARD BTA?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms1,598,22713.3%
Individual Insiders1,970,33916.3%
Institutions3,719,91930.9%
General Public4,767,50339.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.8%.

Top Shareholders

Top 19 shareholders own 60.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.7%
Jan Stahlberg
1,649,197SEK 44.2m0%no data
13.3%
Industrifonden
1,598,227SEK 42.8m71.2%6.26%
9.61%
Swedbank Robur Fonder AB
1,158,688SEK 31.1m73.8%no data
9.21%
M2 Asset Management AB (publ)
1,110,818SEK 29.8m0%0.43%
5.42%
Avanza Fonder AB
653,443SEK 17.5m13.2%0.02%
2.93%
Strand Kapitalforvaltning AB
352,756SEK 9.5m0%93.29%
2.29%
Axel Karlsson
276,552SEK 7.4m0%no data
1.93%
Nordnet AB (publ), Asset Management Arm
233,249SEK 6.3m0%0.09%
0.93%
Futur Pension Försäkringsaktiebolag, Asset Management Arm
112,000SEK 3.0m0%0.1%
0.81%
Alla MÖLler AB, Asset Management Arm
98,050SEK 2.6m0%100.0%
0.21%
Tobias Agervald
25,140SEK 673.8k0%no data
0.052%
Johan Bygge
6,286SEK 168.5k0%no data
0.05%
Johannes Hulthe
6,000SEK 160.8k0%no data
0.024%
Karin Botha
2,845SEK 76.3k0%no data
0.016%
Sara Thuresson
1,950SEK 52.2k0%no data
0.011%
Goran Forsberg
1,369SEK 36.7k0%no data
0.0076%
FCG Fonder AB
915SEK 24.5k0%no data
0.0066%
Lars Hockenstrom
800SEK 21.5k0%no data
0.0017%
Torbjorn Larsson
200SEK 5.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/09 09:42
End of Day Share Price 2024/10/09 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guard Therapeutics International AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ludvig SvenssonCarnegie Commissioned Research
Lars HevrengDanske Bank
Hans MählerNordea Markets